Technical Analysis for PROG - Progenity, Inc.

Grade Last Price % Change Price Change
grade F 8.75 2.58% 0.22
PROG closed up 2.58 percent on Friday, September 25, 2020, on 74 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical PROG trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Inside Day Range Contraction 0.00%
20 DMA Resistance Bearish 2.58%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.58%
Inside Day Range Contraction 2.58%
20 DMA Resistance Bearish 0.46%
Outside Day Range Expansion 0.46%
Lower Bollinger Band Touch Weakness 0.46%
Older End-of-Day Gignals for PROG ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 2% 2 days ago
Up 1% 2 days ago
Down 5% 3 days ago
60 Minute Opening Range Breakdown 3 days ago
Down 3% 3 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Progenity, Inc. is a biotechnology company with an established track record of success in developing and commercializing molecular testing products, as well as innovating in the field of precision medicine. Progenity provides in vitro molecular tests designed to improve lives by providing actionable information that helps guide patients and physicians in making medical decisions during key life stages. The company applies a multi-omics approach, combining genomics, epigenomics, proteomics, and metabolomics to its molecular testing products and to the development of a suite of investigational ingestible devices designed to provide precise diagnostic sampling and drug delivery solutions. Progenity’s vision is to transform healthcare to become more precise and personal by improving diagnoses of disease and improving patient outcomes through localized treatment with targeted therapies.
Biotechnology Healthcare Biology Disease Genomics Drug Delivery Precision Medicine Proteomics Systems Biology Omics Systems Science

Is PROG a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 15.92
52 Week Low 7.63
Average Volume 75,034
200-Day Moving Average 0.00
50-Day Moving Average 8.98
20-Day Moving Average 8.87
10-Day Moving Average 8.81
Average True Range 0.74
ADX 13.65
+DI 13.46
-DI 16.34
Chandelier Exit (Long, 3 ATRs ) 7.53
Chandelier Exit (Short, 3 ATRs ) 10.27
Upper Bollinger Band 9.62
Lower Bollinger Band 8.13
Percent B (%b) 0.42
BandWidth 16.81
MACD Line -0.13
MACD Signal Line -0.10
MACD Histogram -0.0283
Fundamentals Value
Market Cap 36.27 Thousand
Num Shares 4.15 Thousand
EPS 0.61
Price-to-Earnings (P/E) Ratio 14.46
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.17
Resistance 3 (R3) 9.14 8.98 9.10
Resistance 2 (R2) 8.98 8.87 8.99 9.08
Resistance 1 (R1) 8.86 8.80 8.89 8.89 9.05
Pivot Point 8.70 8.70 8.71 8.71 8.70
Support 1 (S1) 8.58 8.59 8.61 8.61 8.45
Support 2 (S2) 8.42 8.52 8.43 8.42
Support 3 (S3) 8.30 8.42 8.40
Support 4 (S4) 8.33